Indivior Pharmaceuticals (INDV) Research & Development (2024 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Research & Development of $16.0 million for Q1 2026, down 27.27% year-over-year from $22.0 million in Q1 2025, and down 23.81% quarter-over-quarter from $21.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Research & Development (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Research & Development history runs 3 years deep, the most recent figure standing at $16.0 million for Q1 2026.
- In Q1 2026, Research & Development fell 27.27% year-over-year to $16.0 million; the TTM figure through Mar 2026 stood at $91.0 million (down 9.9% YoY), while the FY2025 annual figure was $97.0 million, down 9.35% from the prior year.
- Research & Development for Q1 2026 stood at $16.0 million, down from $21.0 million in the prior quarter.
- The five-year high for Research & Development was $33.0 million in Q3 2025, with the low at $16.0 million in Q1 2026.
- The 3-year median for Research & Development is $22.0 million (2024), against an average of $24.4 million.
- Peak annual rise in Research & Development reached 50.0% in 2025, while the deepest fall reached 32.26% in 2025.
- Indivior Pharmaceuticals' Research & Development stood at $31.0 million in 2024, then sank by 32.26% to $21.0 million in 2025, then dropped by 23.81% to $16.0 million in 2026.
- Business Quant data shows INDV's Research & Development at $16.0 million in Q1 2026, $21.0 million in Q4 2025, and $33.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Indivior Pharmaceuticals | 4.59 Bn | 4.37 Bn | 294.00 Mn | 12.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.00 Mn |
| Mar 31, 2026 | 16.00 Mn |
| Dec 31, 2025 | 21.00 Mn |
| Sep 30, 2025 | 33.00 Mn |
| Jun 30, 2025 | 21.00 Mn |
| Mar 31, 2025 | 22.00 Mn |
| Dec 31, 2024 | 31.00 Mn |
| Sep 30, 2024 | 22.00 Mn |
| Jun 30, 2024 | 26.00 Mn |
| Mar 31, 2024 | 28.00 Mn |